Longitudinal Monitoring of CA125 Levels Provides Additional Information About Survival in Ovarian Cancer

Journal of Ovarian Research - United Kingdom
doi 10.1186/1757-2215-3-22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer

Cancer Prevention Research
MedicineCancer ResearchOncology
2019English

Chronic Medical Conditions and CA125 Levels Among Women Without Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

High Levels of Pretreatment CA125 Are Associated to Improved Survival in High Grade Serous Ovarian Carcinoma

Journal of Ovarian Research
GynecologyOncologyObstetrics
2016English

Predictors of Pretreatment CA125 at Ovarian Cancer Diagnosis: A Pooled Analysis in the Ovarian Cancer Association Consortium

Cancer Causes and Control
Cancer ResearchOncology
2017English

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Use of a Symptom Index, CA125, and HE4 to Predict Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

The Efficacy of YKL-40 and CA125 as Biomarkers for Epithelial Ovarian Cancer

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2010English

CA125-Monitoring in Der Nachsorge Des Ovarialkarzinoms

Forum Médical Suisse ‒ Swiss Medical Forum
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy